Law360 (November 6, 2019, 7:27 PM EST) -- The Federal Trade Commission on Wednesday ordered leading prosthetic manufacturer Otto Bock to undo its acquisition of a rival in the market for microprocessor-driven knees, finding that the deal has already harmed competition.
The commission voted 5-0 to uphold Chief Administrative Law Judge D. Michael Chappell's May decision that found Otto Bock HealthCare GmbH's acquisition of Freedom Innovations caused undue concentration in the market for prosthetic knees equipped with microprocessors.
Otto Bock completed the deal for Freedom with private equity firm Health Evolution Partners in September 2017 and the FTC challenged it several weeks later.
The transaction did not meet minimum...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!